Glowing dye could reveal invisible cancer clues in the esophagus
NCT ID NCT07643727
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a fluorescent tracer called WGA-800CW can make precancerous or cancerous cells in Barrett's esophagus glow during endoscopy. The tracer is sprayed onto the esophagus, and special cameras detect the glow. The goal is to find the best dose and see if this method can spot dysplasia that standard scopes miss. About 49 adults with Barrett's esophagus will take part.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
WGA-800CW (a fluorescent tracer made from wheat germ agglutinin)
What this could lead to
If successful, this imaging technique could help doctors find precancerous spots in Barrett's esophagus that are invisible under standard endoscopy, enabling earlier treatment.
What could go wrong
This is an early pilot study with only 49 participants, so results may not apply to everyone. The tracer is sprayed directly onto the esophagus, and its safety and effectiveness are still being tested.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BARRETT ESOPHAGUS ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Medical Center Groningen
Groningen, Provincie Groningen, 9713 GZ, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact